Top Clinical Trials companies in United States by Total Liabilities

This ranking features the top 532 Clinical Trials companies in United States ranked by Total Liabilities, totaling a Total Liabilities of USD 1.10 T, for July 08, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

…

Frequently Asked Questions

Which Clinical Trials company in United States has the highest Total Liabilities ?

The Clinical Trials company in United States with the highest Total Liabilities is AbbVie Inc. (NYSE: ABBV) at USD 131.80 B.

Which Clinical Trials company in United States has the lowest Total Liabilities ?

The Clinical Trials company in United States with the lowest Total Liabilities is AN2 Therapeutics, Inc. (NasdaqGS: ANTX) at None.

What are the top 10 Clinical Trials companies in United States by Total Liabilities ?

The top 10 Clinical Trials companies in United States by Total Liabilities are AbbVie Inc., Pfizer Inc., Amgen Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Cencora, Inc., Eli Lilly and Company, Thermo Fisher Scientific Inc., Gilead Sciences, Inc. and Abbott Laboratories.

What are the bottom 10 Clinical Trials companies in United States by Total Liabilities ?

The bottom 10 Clinical Trials companies in United States by Total Liabilities are AN2 Therapeutics, Inc., Alto Neuroscience, Inc., Annexon, Inc., Anixa Biosciences, Inc., Aclaris Therapeutics, Inc., Aclarion, Inc., Actuate Therapeutics Inc, Anebulo Pharmaceuticals, Inc., Alzamend Neuro, Inc. and Annovis Bio, Inc..